Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis

Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis

(2013) Yuji Kasukawa et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial

(2011) Ralf Westenfeld et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases

(2010) Akimitsu Miyauchi et al.   BONE

Vitamins K and D Status in Stages 3-5 Chronic Kidney Disease

(2010) R. M. Holden et al.   Clinical Journal of the American Society of Nephrology

High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment

(2010) Masataka Shiraki et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women

(2010) Pawel Szulc et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

(2010) I. Kanazawa et al.   OSTEOPOROSIS INTERNATIONAL

Significant Association of Fracture of the Lumbar Spine with Mortality in Female Hemodialysis Patients: A Prospective Observational Study

(2009) Yoshifumi Maeno et al.   CALCIFIED TISSUE INTERNATIONAL

Prevalence of chronic kidney disease in the Japanese general population

(2009) Enyu Imai et al.   Clinical and Experimental Nephrology

Carboxylation of Osteocalcin Affects Its Association With Metabolic Parameters in Healthy Children

(2009) A. Prats-Puig et al.   DIABETES CARE

Serum Levels of TRAP5b, a New Bone Resorption Marker Unaffected by Renal Dysfunction, as a Useful Marker of Cortical Bone Loss in Hemodialysis Patients

(2008) Kaori Shidara et al.   CALCIFIED TISSUE INTERNATIONAL

Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction

(2008) Shinsuke Yamada et al.   CLINICAL ENDOCRINOLOGY

Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects

(2008) Yoshiki Nishizawa et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

(2008) Ippei Kanazawa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM